BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32014926)

  • 1. VDR Agonists Increase Sensitivity of MCF-7 and BT-474 Breast Cancer Cells to 5 FU.
    Klopotowska D; Matuszyk J
    Anticancer Res; 2020 Feb; 40(2):837-840. PubMed ID: 32014926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid hormone calcitriol and its analog tacalcitol inhibit miR-125b expression in a human breast cancer MCF-7 cell line.
    Klopotowska D; Matuszyk J; Wietrzyk J
    Steroids; 2019 Jan; 141():70-75. PubMed ID: 30503385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cdx2 polymorphism affects the activities of vitamin D receptor in human breast cancer cell lines and human breast carcinomas.
    Pulito C; Terrenato I; Di Benedetto A; Korita E; Goeman F; Sacconi A; Biagioni F; Blandino G; Strano S; Muti P; Mottolese M; Falvo E
    PLoS One; 2015; 10(4):e0124894. PubMed ID: 25849303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-Regulation of Ca
    Khatun A; Fujimoto M; Kito H; Niwa S; Suzuki T; Ohya S
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27973439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells.
    Wietzke JA; Welsh J
    J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):149-57. PubMed ID: 12710998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D Compounds PRI-2191 and PRI-2205 Enhance Anastrozole Activity in Human Breast Cancer Models.
    Filip-Psurska B; Psurski M; Anisiewicz A; Libako P; Zbrojewicz E; Maciejewska M; Chodyński M; Kutner A; Wietrzyk J
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer.
    Thakkar A; Wang B; Picon-Ruiz M; Buchwald P; Ince TA
    Breast Cancer Res Treat; 2016 May; 157(1):77-90. PubMed ID: 27120467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel nonsecosteroidal VDR agonists with phenyl-pyrrolyl pentane skeleton.
    Shen W; Xue J; Zhao Z; Zhang C
    Eur J Med Chem; 2013 Nov; 69():768-78. PubMed ID: 24099996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of ER and VDR is not sufficient to make ER-negative MDA-MB231 breast cancer cells responsive to 1alpha-hydroxyvitamin D5.
    Peng X; Jhaveri P; Hussain-Hakimjee EA; Mehta RG
    Carcinogenesis; 2007 May; 28(5):1000-7. PubMed ID: 17130524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiestrogen potentiation of antiproliferative effects of vitamin D3 analogues in breast cancer cells.
    Love-Schimenti CD; Gibson DF; Ratnam AV; Bikle DD
    Cancer Res; 1996 Jun; 56(12):2789-94. PubMed ID: 8665515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism of VDR Gene and the Sensitivity of Human Leukemia and Lymphoma Cells to Active Forms of Vitamin D.
    Gleba JJ; Kłopotowska D; Banach J; Turlej E; Mielko KA; Gębura K; Bogunia-Kubik K; Kutner A; Wietrzyk J
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D-induced vitamin D receptor expression induces tamoxifen sensitivity in MCF-7 stem cells via suppression of Wnt/β-catenin signaling.
    Zheng W; Duan B; Zhang Q; Ouyang L; Peng W; Qian F; Wang Y; Huang S
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30314996
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulation of MAPK ERK1 and ERK2 in VDR-positive and -negative breast cancer cell lines.
    Cordes T; Diesing D; Becker S; Diedrich K; Reichrath J; Friedrich M
    Anticancer Res; 2006; 26(4A):2749-53. PubMed ID: 16886687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bystander killing of breast cancer MCF-7 cells by MDA-MB-231 cells exposed to 5-fluorouracil is mediated via Fas.
    Chhipa RR; Bhat MK
    J Cell Biochem; 2007 May; 101(1):68-79. PubMed ID: 17340621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. l-arginine alters the effect of 5-fluorouracil on breast cancer cells in favor of apoptosis.
    Jahani M; Azadbakht M; Norooznezhad F; Mansouri K
    Biomed Pharmacother; 2017 Apr; 88():114-123. PubMed ID: 28103504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel nonsteroidal VDR agonists with novel diarylmethane skeleton for the treatment of breast cancer.
    Wang C; Wang B; Hou S; Xue L; Kang Z; Du J; Li Y; Liu X; Wang Q; Zhang C
    Eur J Med Chem; 2019 Feb; 163():787-803. PubMed ID: 30579121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D receptors in breast cancer cells.
    Buras RR; Schumaker LM; Davoodi F; Brenner RV; Shabahang M; Nauta RJ; Evans SR
    Breast Cancer Res Treat; 1994; 31(2-3):191-202. PubMed ID: 7881099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptotic activity of 5-fluorouracil in breast cancer cells transformed by low doses of ionizing α-particle radiation.
    Ponce-Cusi R; Calaf GM
    Int J Oncol; 2016 Feb; 48(2):774-82. PubMed ID: 26691280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines.
    Elstner E; Linker-Israeli M; Said J; Umiel T; de Vos S; Shintaku IP; Heber D; Binderup L; Uskokovic M; Koeffler HP
    Cancer Res; 1995 Jul; 55(13):2822-30. PubMed ID: 7796409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-exposure to 50 Hz-electromagnetic fields enhanced the antiproliferative efficacy of 5-fluorouracil in breast cancer MCF-7 cells.
    Han Q; Chen R; Wang F; Chen S; Sun X; Guan X; Yang Y; Peng B; Pan X; Li J; Yi W; Li P; Zhang H; Feng D; Chen A; Li X; Li S; Yin Z
    PLoS One; 2018; 13(4):e0192888. PubMed ID: 29617363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.